Vaccine containing tumor antigens and adjuvants

Details Vaccine containing tumor antigens and adjuvants Vaccine containing tumor antigens and adjuvants

1987-09-30

1989-10-31

Terapane, John F.

Drug, bio-affecting and body treating compositions

Lymphokine

514885, 514937, 514938, 514934, 514943, A61K 3939, A61K 3904

Patent

active

048776114

ABSTRACT:
Vaccines are provided which are composed of (a) non-toxic and highly effective adjuvants obtained from microbial sources, together with (b) tumor antigens. A wide variety of antigens can be employed in the vaccines and include, antigens obtained from tumors or cultures of tumor cells, such as ovarian cancers, melanomas, colorectal cancers, pancreatic cancers, renal cancers and the like. By adding tumor antigens to potent but non-toxic immunostimulants, a protective and lasting tumor immunity can be obtained.

REFERENCES:
patent: 4036953 (1977-07-01), Adam et al.
patent: 4307229 (1981-12-01), Liav et al.
patent: 4338334 (1982-07-01), Jensen et al.
patent: 4606918 (1986-08-01), Allison et al.

Affiliated with

Also associated with

Rating

Vaccine containing tumor antigens and adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine containing tumor antigens and adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine containing tumor antigens and adjuvants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-624647